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Abstract
Background: In developing countries where Plasmodium falciparum malaria is endemic, viral
encephalitis and cerebral malaria are found in the same population, and parasitemia with Plasmodium
falciparum is common in asymptomatic children. The objective of this study was to investigate the
cerebrospinal fluid (CSF) biochemistry in children with cerebral malaria compared to those with
presumed viral encephalitis.
Methods: We studied the following CSF parameters: cell count, glucose, protein, lactic
dehydrogenase (LDH) and adenosine deaminase (ADA) levels, in children with cerebral malaria,
with presumed viral encephalitis, and in control subjects who had a lumbar puncture after a febrile
convulsion with postictal coma.
Results: We recruited 12 children with cerebral malaria, 14 children with presumed viral
encephalitis and 20 controls prospectively, over 2 years in the Government General Hospital in
Kakinada, India. Patients with cerebral malaria had significantly lower CSF glucose, and higher
protein, LDH, CSF/blood LDH ratio and CSF ADA levels but a lower CSF/serum ADA ratio
compared to controls (p < 0.01). Patients with cerebral malaria had lower CSF white cell count,
glucose, protein, LDH levels and CSF/serum ADA ratio compared to patients with presumed viral
encephalitis. CSF/serum ADA ratio was lower in patients with cerebral malaria due to the fact that
serum ADA levels were significantly higher in patients with cerebral malaria compared to the other
two groups. A CSF/serum ADA ratio of <0.38 and a CSF glucose level of <3.4 mmol/l were selected
as the cut-off values with the highest sensitivities and specificities for comparing the two conditions.
Conclusion: CSF/serum ADA ratio and CSF glucose levels were the best discriminators of
cerebral malaria from presumed viral encephalitis in our study. Further studies are needed to
explore their usefulness in epidemiological studies.
Background
Previous studies have compared cerebrospinal fluid (CSF)
features of bacterial meningitis and cerebral malaria [1,2].
This distinction is in most cases not difficult, because the
majority of patients with bacterial meningitis have
marked CSF pleocytosis, in contrast to cerebral malaria
where this is uncommon. More difficult is the distinction
of cerebral malaria from viral encephalitis on clinical
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nostic methods are not available in most developing
countries. With the benefit of acyclovir in herpes encepha-
litis for prevention of death or neurological sequelae [3],
and the need to recognize the presence of possible arbovi-
rus encephalitis with its public health implications [4], it
has become more important to differentiate viral
encephalitis from cerebral malaria. The objective of our
study was, therefore, to investigate the distinguishing fea-
tures of a variety of CSF parameters in patients with cere-
bral malaria as opposed to those with presumed viral
encephalitis. We have chosen for our investigation CSF
cell count, glucose and protein levels, together with CSF
and serum lactic dehydrogenase (LDH) and adenosine
deaminase (ADA). Previous investigations have found
that these parameters may be useful in discrimination of
infectious diseases of the central nervous system such as
meningitis, encephalitis and cerebral malaria [5,6]. Lactic
dehydrogenase is an intracellular enzyme that is released
from damaged cells. Its level in the CSF reflects the degree
of damage to cells in the central nervous system. CSF- ade-
nosine deaminase, an enzyme mainly produced by devel-
oping immature T-lymphocytes, is increased in the body
fluids of patients with conditions associated with stimula-
tion of cellular immunity and was evaluated in this study
for its use in differentiation of parasitic and viral infection
of the brain.
Methods
Patients
In a 2-year prospective study at Government General hos-
pital in Kakinada, India we recruited with ethical approval
and informed consent by parents or guardians, children
with a clinical diagnosis of presumed viral encephalitis,
cerebral malaria and controls. The definition of presumed
viral encephalitis was a reduced level of consciousness
and pyrexia that could not be explained by a metabolic
abnormality, dehydration or shock, negative blood and
CSF cultures, and a negative blood slide for malaria para-
sites with recovery without antibiotics or lack of response
to broad-spectrum antibiotics [7]. Cerebral malaria was
defined as coma and pyrexia with a positive thick film for
asexual P. falciparum blood stages and no other identified
cause of an encephalopathy following the WHO defini-
tion [8]. We recruited control subjects from a population
of patients who had lumbar punctures to exclude menin-
gitis in the context of reduced consciousness following
febrile convulsions and who recovered from the postictal
state without further signs of central nervous system ill-
ness or septicaemia.
Sample collection and analysis
CSF was obtained by lumbar puncture as soon as possible
after admission if there were no contraindications, and
after informed consent by the parents. CSF cell count, glu-
cose, protein and CSF and serum LDH levels were deter-
mined by standard methods as in a previous study
published by this group [9]. ADA levels were determined
using the Berthelot reaction, through the ammonia
released when adenosine is broken down to inosine. After
incubation of plasma or CSF with a buffered solution of
adenosine, the ammonia is reacted with a Berthelot rea-
gent to form a blue colour, which is proportional to the
amount of enzyme activity [10].
Data analysis
For multiple comparisons of data with an approximately
normal distribution the one way analysis of variance
(ANOVA) was used. Tukey's HSD test was used for post
hoc analysis of these data. For non-parametric data the
Kruskal-Wallis test was used. The statistical method used
for univariate comparisons of continuous data was the
Mann-Whitney test, and for categorical data the chi-
square test. For determination of a cutoff value for a CSF
parameter for possible discrimination between presumed
viral encephalitis and cerebral malaria, the co-ordinate of
a receiver operating characteristic (ROC) curve indicating
the greatest sensitivity and specificity was chosen (for
explanation of the statistical methodology see [11]). The
ROC curve is a computer-generated curve of data from the
malaria and viral encephalitis patients with sensitivity on
the vertical axis plotted against 1-specificity (1-true nega-
tive rate) on the horizontal axis. Sensitivity is the true pos-
itive rate in percent and it was calculated from the ratio of
the number of true positive over the sum of true positive
and false negative patients. True positive in the context of
this study, was the presence of cerebral malaria in any
patient below a certain value of a parameter, the 'cut-off'.
Specificity is the true negative rate in percent and it was
calculated as the ratio of the number of true negative over
the sum of false positive and true negative patients. True
negative meant the patient has presumed viral encephali-
tis if the parameter is above the "cut-off" chosen (Table 2).
The positive predictive value is the post-test probability of
a positive test and negative predictive value the post-test
probability of a negative test [12]. The positive predictive
value is calculated as the ratio of the number of true posi-
tive over the sum of true positive and false positive
patients. The negative predictive value is the ratio of the
number of true negative over the sum of false negative and
true negative patients. The probability for the positive pre-
dictive value was the probability of having cerebral
malaria in any patient and for the negative predictive
value, the probability of having presumed viral encepha-
litis. A p-value < 0.05 was taken as indicator for a statisti-
cally significant difference. Statistical calculations were
performed with SPSS version 13.0 and Epi Info 6.04b
(CDC, Atlanta). Confidence intervals for parameters were
calculated by Confidence Interval Analysis software.Page 2 of 7
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46 children were recruited over a 2-year period. Twelve
patients had cerebral malaria, 14 patients presumed viral
encephalitis and 20 patients were controls. Demographic
and laboratory parameters including LDH and ADA CSF/
serum ratios are listed in Table 1. There was no significant
difference in age between patients with cerebral malaria
and presumed viral encephalitis, although both groups
were both significantly older than controls. The CSF white
cell count was significantly higher in the group with pre-
sumed viral encephalitis compared to patients with cere-
bral malaria or controls. The mean CSF glucose level was
significantly lower in patients with cerebral malaria com-
pared to the other two groups and the range for glucose
levels in patients with cerebral malaria did not overlap
with that for patients with presumed viral encephalitis
(Figure 1). Patients with cerebral malaria had significantly
higher CSF protein, LDH and ADA levels and CSF/serum
LDH ratio but a lower CSF/serum ADA ratio, compared to
controls (Table 1). Patients with cerebral malaria had sig-
Table 1: Comparison of demographic and cerebrospinal fluid parameters between patients with cerebral malaria, presumed viral 
encephalitis and controls.
Cerebral malaria n = 12 Presumed viral encephalitis 
n = 14
Controls n = 20 p-value for multiple 
comparisons
Age (years) 7.0 (2.7) 7.0 (3.5) 1.7 (1.2) <0.01a
Gender (male) 7 6 9 nsb
CSF-parameters:
White cells (cells/µl)c 0 (0–3) 4 (0–9) 0 (0–4) <0.01d
Glucose (mmol/l) 2.7 (0.3) 4.2 (0.4) 3.3 (0.6) <0.01a
Protein (g/l) 0.4 (0.04) 0.5 (0.06) 0.3 (0.10) <0.01a
CSF-ADA (IU/l) 4.6 (0.9) 3.8 (1.0) 3.3 (0.8) <0.01a
Serum ADA (IU/l)c 14.4 (11.6–17.5) 6.5 (4.8–10.1) 6.1 (4.4–8.9) <0.01d
Ratio CSF/serum ADA 0.31 (0.05) 0.54 (0.11) 0.53 (0.13) <0.01a
CSF-LDH (IU/ml) 20.7 (2.8) 26.5 (5.8) 15.9 (3.8) <0.01a
Serum LDH (IU/ml) 214.1 (25.7) 247.5 (46.8) 244.0 (57.7) ns a
Ratio CSF/serum LDH 0.09 (0.02) 0.11 (0.02) 0.07 (0.01) <0.01a
LDH = Lactic dehydrogenase, ADA = Adenosine deaminase. Results where applicable are given as mean (SD). a Analysis of variance: Post hoc 
analysis results with p < 0.05 (Tukey HSD test): Age: Cerebral malaria and presumed viral encephalitis versus controls. CSF white cell count: Cerebral 
malaria versus presumed viral encephalitis and presumed viral encephalitis versus controls. Glucose and protein: Each group versus the 2 other 
groups. CSF-ADA: Cerebral malaria versus controls. Serum ADA: Cerebral malaria versus the 2 other groups. Ratio CSF/serum ADA: Cerebral malaria 
versus the two 2 groups. CSF-LDH: Each group versus the other 2 groups. Ratio CSF/serum LDH: Cerebral malaria and presumed viral encephalitis 
versus controls. b ns = not significant by chi-square test. c Median and range. d Kruskal-Wallis test.
Table 2: Cerebrospinal fluid parameters as discriminators between cerebral malaria and presumed viral encephalitis
Cut-off Sensitivity1 (%) Specificity2 (%) Negative predictive Value3 
(%)
Positive predictive Value4 
(%)
(95% CI) (95% CI) (95% CI) (95% CI)
CSF white cell count <4 
cells/microl
100 (76–100) 57 (32–78) 100 (67–100) 66 (43–83)
CSF protein <0.43 g/l 92 (64–98) 78 (52–92) 91 (64–98) 78 (52–92)
CSF glucose <3.4 mmol/l 100 (78–100) 100 (75–100) 100 (75–100) 100 (78–100)
Ratio CSF/serum ADA 
<0.385
91 (64–98) 100 (78–100) 93 (70–100) 100 (74–100)
CSF LDH < 22.5 IU/ml 75 (46–91) 71 (44–88) 76 (49–92) 69 (42–87)
1Sensitivity is the true positive rate in percent. It is calculated as the ratio of the number of true positive over the sum of true positive and false 
negative patients. True positive meant in the context of this study the presence of cerebral malaria in a group of patients with presumed viral 
encephalitis or cerebral malaria below a certain value of a parameter, the "cut-off". 2Specificity is the true negative rate in percent. It is calculated as 
the ratio of the number of true negative over the sum of false positive and true negative patients. True negative meant the patient has presumed 
viral encephalitis if the parameter is above the "cut-off" chosen. 3The negative predictive value is the ratio of the number of true negative over the 
sum of false negative and true negative patients. Positive predictive value is the post-test probability of a positive test and negative predictive value 
the post-test probability of a negative test. 4The positive predictive value is calculated as the ratio of the number of true positive over the sum of 
true positive and false positive patients.Page 3 of 7
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CSF/serum ADA ratios compared to patients with pre-
sumed viral encephalitis (Table 1). Patients with cerebral
malaria had a significantly higher serum ADA level com-
pared to patients with presumed viral encephalitis and to
controls (Mann-Whitney test, p < 0.05, Figure 2). Serum
ADA levels in patients with presumed viral encephalitis
were not significantly different from controls (p > 0.05).
Serum LDH levels were not significantly different between
groups (p > 0.05). However, CSF/Serum LDH ratios for
both patients with cerebral malaria and presumed viral
encephalitis were significantly higher than controls.
For markers with a significant difference between cerebral
malaria and the presumed viral encephalitis groups, we
determined cut-off values of CSF parameters with maxi-
mum sensitivities and specificities and positive and nega-
tive predictive values. The best cut-off values taken from
the co-ordinates of the ROC curve (see methods section)
below which cerebral malaria was more likely than pre-
sumed viral encephalitis were: CSF white cell count, 4
cells/µl; CSF protein level, 0.43 g/l; CSF glucose, 3.4
mmol/l; CSF LDH, 22.5 IU/ml; CSF/serum ADA ratio,
0.385 (Table 2).
CSF white cell count, protein and glucose levels and CSF/
serum ADA ratio below these cut-off values indicated cer-
ebral malaria with a sensitivity of > 90%. This resulted in
the probability of having presumed viral encephalitis in
our group of children with cerebral malaria or viral
encephalitis (or negative predictive value for having cere-
bral malaria) being above 90% if the values of these
parameters were above this cut-off. Specificities for the
parameters were 100% for CSF glucose and 100% for CSF/
serum ADA ratio and better than for other parameters, i.e.
presumed viral encephalitis was always present in any
patient with a value above the cut-off. This resulted in a
probability (positive predictive value) of 100% of having
Scatter plot of CSF glucose levels in patients with cerebral malaria, presumed viral encephalitis and controlsFigure 1
Scatter plot of CSF glucose levels in patients with cerebral malaria, presumed viral encephalitis and controls.
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cut-off (Table 2).
Discussion
This is to our knowledge the first study to investigate dif-
ferences in CSF parameters between presumed viral
encephalitis and cerebral malaria. Asymptomatic parasi-
taemia with Plasmodium falciparum is common in regions
hyperendemic for this parasite. In many of these areas,
particularly in South East Asia, viral encephalitis is also a
public health problem. It is therefore important to inves-
tigate discriminating CSF features between encephalitis
and cerebral malaria. Our study is the most detailed study
on CSF parameters in cerebral malaria reported so far. We
could not, however, exclude the possibility that patients
labeled as having cerebral malaria had a combination of
encephalitis and parasitaemia with P. falciparum, but the
lack of white cells in their cerebrospinal fluid make this
possibility seem very unlikely.
CSF-glucose
A CSF glucose level below 3.4 mmol/l was the best dis-
criminator of cerebral malaria from presumed viral
encephalitis. This was partly due to the fact that in cerebral
malaria CSF glucose levels were below normal range. Low
CSF glucose is a well-known phenomenon in cerebral
Box plot of serum adenosine deaminase levels in patients with cerebral malaria, presumed viral encephalitis and controlsFigure 2
Box plot of serum adenosine deaminase levels in patients with cerebral malaria, presumed viral encephalitis and controls. The 
line inside the box represents the median, the box the quartiles, and the whiskers the extreme values.
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patients with fatal cerebral malaria as compared to survi-
vors [13]. However, the low CSF glucose may be partly
due to low plasma glucose levels not measured in this
study, but previously found in falciparum malaria [14].
The previous study found CSF glucose levels of up to 7
mmol/l in patients with cerebral malaria and mean levels
of 4.3 mmol/l in survivors, which indicates that a discrim-
inator of 3.4 mmol/l between cerebral malaria and
encephalitis may not be universally applicable, but
dependent on disease severity [13]. Febrile convulsions
were an indication for lumbar puncture in the control
patients. Consequently the control patients in our study
were significantly younger than the disease cases, due to
the young age at which febrile convulsions usually occur.
CSF glucose levels are independent of age above 2 months
of age with lower levels found in infants below this age
[15]. All the children in our study were older than 3
months and therefore the observed differences were not
age related. Elevated CSF glucose has been described in
cases of viral encephalitis [16] and this may have contrib-
uted to the significant difference found here between the
two groups.
CSF-protein
Previous studies with data on CSF in cerebral malaria also
found increased total protein levels [17,18]. Our result of
increased cerebrospinal fluid protein levels in presumed
viral encephalitis has also been found in patients with her-
pes encephalitis [19,20].
Adenosine deaminase
We found that a CSF/serum ADA ratio of <0.38 was the
best discriminator of cerebral malaria from presumed
viral encephalitis. CSF ADA levels were measured in 3
patients with cerebral malaria previously, and found to
have a mean (SD) of 6.6 (1.03) IU/l [5], slightly higher
than the levels in our study (4.6 (0.9) IU/l). There has
been no previous investigation of serum ADA levels in P.
falciparum malaria but serum ADA levels were found to be
elevated to more than twice the level of controls in a pre-
vious study on patients with Plasmodium vivax malaria
[21]. CSF ADA levels in a previous study containing data
on 10 patients with viral encephalitis were found to have
a mean (SD) of 6.15 (2.93) [6], which is higher than the
levels reported here (3.8 (1.0) IU/l). Although the etiolog-
ical agent of the presumed viral encephalitis was not
determined, it was most likely to be a heterogeneous
group over the 2-year period during which the patients
were recruited [22].
Lactic dehydrogenase
Mean CSF LDH levels of 26.5 U/ml in our patients with
encephalitis were similar to the means of 22.6 and 22.3 U/
ml found in two previous studies, respectively, [23,24].
Our controls had a slightly lower mean CSF LDH level
than the 20 controls (adults and children without neuro-
logical illness) of a previous study with a mean level of
21.8 U/ml [24]. There is to our knowledge no previous
study on CSF LDH levels in cerebral malaria.
CSF lactate, which is characteristically elevated in cerebral
malaria [13], is another parameter for future studies look-
ing at discriminating features between cerebral malaria
and encephalitis.
Patients with clinical features of encephalitis and a posi-
tive malaria blood slide should still be treated as suffering
from cerebral malaria regardless of the CSF findings, as
our study cannot exclude a possible overlap in CSF/serum
ADA ratios or CSF glucose levels between patients with
encephalitis and cerebral malaria in other settings. The
same applies to epidemiological surveillance pending fur-
ther studies.
Conclusion
CSF adenosine deaminase alone was not a useful discrim-
inator between encephalitis and cerebral malaria. How-
ever, the CSF/serum ADA ratio was lower in patients with
cerebral malaria due to the high levels of ADA in periph-
eral blood. This ratio should be evaluated in future, larger-
scale, investigations into discriminatory factors between
encephalitis and cerebral malaria. Although CSF glucose
was significantly reduced in malaria patients, the results
should be interpreted cautiously and require confirma-
tion in a larger study. It would be preferable to use CSF/
serum glucose ratios for future studies. Large-scale pro-
spective studies in areas where P. falciparum and for exam-
ple, Japanese encephalitis viruses, are both endemic are
needed to validate our findings in different settings.
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